CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project develops a novel drug delivery platform for liver cancer treatment using biodegradable mini-stents that release drugs before blocking blood vessels to induce tumor necrosis. This innovative approach aims to improve treatment outcomes and reduce adverse effects.
This project aims to develop a novel platform for drug delivery and treatment for liver cancers. A first in its kind two-step acting platform is described in detail depicting an early step of drug elusion to viable tissue (in contrast to acute embolism) followed by a later stage of vessel blockage to induce tissue necrosis is introduced here.
Inspired by the coronary drug eluting stent concept we will introduce a novel porous degradable bead referred as EmboPore used as mini-stents that can elut…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
